These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11791016)

  • 1. Anti-atherosclerotic effect of beta-blocker with nitric oxide-releasing action on the severe atherosclerosis.
    Thakur NK; Hayashi T; Sumi D; Kano H; Matsui-Hirai H; Tsunekawa T; Iguchi A
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):298-309. PubMed ID: 11791016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The beta adrenoreceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit.
    Hayashi T; Yamada K; Esaki T; Muto E; Iguchi A
    Life Sci; 1997; 61(14):1379-87. PubMed ID: 9335227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism.
    Hayashi T; Matsui-Hirai H; Fukatsu A; Sumi D; Kano-Hayashi H; Rani P JA; Iguchi A
    Atherosclerosis; 2006 Aug; 187(2):316-24. PubMed ID: 16325187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological concentration of 17beta-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol diet plus balloon catheter injury: role of NO.
    Hayashi T; Jayachandran M; Sumi D; Thakur NK; Esaki T; Muto E; Kano H; Asai Y; Iguchi A
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1613-21. PubMed ID: 10845880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estriol retards and stabilizes atherosclerosis through an NO-mediated system.
    Kano H; Hayashi T; Sumi D; Matusi-Hirai H; Tsunekawa T; Endo H; Iguchi A
    Life Sci; 2002 May; 71(1):31-42. PubMed ID: 12020746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A HMG-CoA reductase inhibitor possesses a potent anti-atherosclerotic effect other than serum lipid lowering effects--the relevance of endothelial nitric oxide synthase and superoxide anion scavenging action.
    Sumi D; Hayashi T; Thakur NK; Jayachandran M; Asai Y; Kano H; Matsui H; Iguchi A
    Atherosclerosis; 2001 Apr; 155(2):347-57. PubMed ID: 11254905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
    Kojda G; Stein D; Kottenberg E; Schnaith EM; Noack E
    J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
    Takamitsu Y; Nakanishi T; Nishihara F; Hasuike Y; Izumi M; Inoue T; Hiraoka K; Itahana R; Miyagawa K
    Nephron Physiol; 2003; 93(2):p42-50. PubMed ID: 12629270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydroepiandrosterone retards atherosclerosis formation through its conversion to estrogen: the possible role of nitric oxide.
    Hayashi T; Esaki T; Muto E; Kano H; Asai Y; Thakur NK; Sumi D; Jayachandran M; Iguchi A
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):782-92. PubMed ID: 10712404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits.
    de Nigris F; Mancini FP; Balestrieri ML; Byrns R; Fiorito C; Williams-Ignarro S; Palagiano A; Crimi E; Ignarro LJ; Napoli C
    Nitric Oxide; 2008 Aug; 19(1):57-63. PubMed ID: 18435936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of hypertension, cardiomyocyte hypertrophy, and myocardial fibrosis by beta-adrenoceptor blockers in rats under long-term blockade of nitric oxide synthesis.
    Pacca SR; de Azevedo AP; De Oliveira CF; De Luca IM; De Nucci G; Antunes E
    J Cardiovasc Pharmacol; 2002 Feb; 39(2):201-7. PubMed ID: 11791005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of endothelial nitric oxide synthase through beta(2)-adrenergic receptor--the role of a beta-blocker with NO-releasing action.
    Jayachandran M; Hayashi T; Sumi D; Thakur NK; Kano H; Ignarro LJ; Iguchi A
    Biochem Biophys Res Commun; 2001 Jan; 280(3):589-94. PubMed ID: 11162560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 17beta-estradiol in hypercholesterolemic rabbits with severe endothelial dysfunction.
    Nascimento CA; Kauser K; Rubanyi GM
    Am J Physiol; 1999 May; 276(5):H1788-94. PubMed ID: 10330264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. PGH2 does not contribute to impaired endothelium-dependent relaxation.
    Naruse K; Shimizu K; Muramatsu M; Toki Y; Miyazaki Y; Okumura K; Hashimoto H; Ito T
    Arterioscler Thromb; 1994 May; 14(5):746-52. PubMed ID: 8172852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function.
    Horimoto H; Saltman AE; Gaudette GR; Krukenkamp IB
    Ann Thorac Surg; 1999 Sep; 68(3):844-9. PubMed ID: 10509972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits.
    Noguchi K; Yamashiro S; Matsuzaki T; Sakanashi M; Nakasone J; Miyagi K; Sakanashi M
    Br J Pharmacol; 2001 Jun; 133(3):395-405. PubMed ID: 11375256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Endothelium and nitric oxide].
    Garaliene V
    Medicina (Kaunas); 2008; 44(7):564-9. PubMed ID: 18695354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production.
    Böger RH; Bode-Böger SM; Mügge A; Kienke S; Brandes R; Dwenger A; Frölich JC
    Atherosclerosis; 1995 Oct; 117(2):273-84. PubMed ID: 8801873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.